Microbix Reports Results for Q3 Fiscal 2026
MBX Biosciences Highlights Sustained Calcium Control In Rare Disease
Microbix Schedules Release of Results for Q2 Fiscal 2026
Microbix Product Results Being Presented at 2026 PASCV
Microbix Engages with Diagnostics Industry Experts
Microbix Presenting at the 2026 Bloom Burton Conference
Microbix's Clot-Buster Drug Project Advances
Microbix Reports Results for Q1 2026
Microbix Presents Molecular Pathology Platform Results